| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 12/02/2014 | US8901277 Interferon alpha mutant and its polyethylene glycol derivative | 
| 12/02/2014 | US8901084 Self-assembling peptide incorporating modifications and methods of use thereof | 
| 12/02/2014 | US8901083 Administration of angiocidin for the treatment of leukemia | 
| 12/02/2014 | US8901082 Immunity-inducing agent and method for detection of cancer | 
| 12/02/2014 | US8901079 Treatment of parkinson's disease via administration of GLI-1 protein | 
| 12/02/2014 | US8901077 Delivery of a gene therapy vector to the brain by convection-enhanced delivery | 
| 12/02/2014 | US8901076 Binding proteins inhibiting the VEGF-A receptor interaction | 
| 12/02/2014 | US8901074 Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases | 
| 12/02/2014 | US8901073 Compounds and their effects on feeding behaviour | 
| 12/02/2014 | US8901070 Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302) | 
| 12/02/2014 | US8901069 Protein matrix for light-initiated electron transfer | 
| 12/02/2014 | US8900880 Viral citrullinated peptides and uses thereof | 
| 12/02/2014 | US8900846 Nucleic acid modifying enzymes | 
| 12/02/2014 | US8900825 Immunogenic proteins of Leptospira | 
| 12/02/2014 | US8900600 Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy | 
| 12/02/2014 | US8900599 Conjugates of Plasmodium falciparum surface proteins as malaria vaccines | 
| 12/02/2014 | US8900597 Compositions relating to a mutant Clostridium difficile toxin and methods thereof | 
| 12/02/2014 | US8900596 Physicochemical (PCP) based consensus sequences and uses thereof | 
| 12/02/2014 | US8900595 Filovirus vectors and noninfectious filovirus-based particles | 
| 12/02/2014 | US8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof | 
| 12/02/2014 | US8900593 Glucagon/GLP-1 receptor co-agonists | 
| 12/02/2014 | US8900591 Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors | 
| 12/02/2014 | US8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds | 
| 12/02/2014 | US8900584 Human CDR-grafted antibody and antibody fragment thereof | 
| 12/02/2014 | US8900583 Methods for treatment of brain injury utilizing biologics | 
| 11/27/2014 | US20140352001 Novel bacillus thuringiensis gene with lepidopteran activity | 
| 11/27/2014 | US20140352000 Novel bacillus thuringiensis gene with lepidopteran activity | 
| 11/27/2014 | US20140351998 Engineering plants for efficient uptake and utilization of urea to improve crop production | 
| 11/27/2014 | US20140351967 Brassica Plant Comprising a Mutant Indehiscent Allele | 
| 11/27/2014 | US20140351960 Artery- and vein-specific proteins and uses therefor | 
| 11/27/2014 | US20140350453 Bonding tissues and cross-linking proteins with naphthalimide compounds | 
| 11/27/2014 | US20140350229 Method for producing synthetic amylospheroid | 
| 11/27/2014 | US20140350223 Enhanced production and purification of a natural high intensity sweetener | 
| 11/27/2014 | US20140350220 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN; pE) | 
| 11/27/2014 | US20140350218 Alpha-conotoxin peptides | 
| 11/27/2014 | US20140349946 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides | 
| 11/27/2014 | US20140349944 Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases | 
| 11/27/2014 | US20140349940 Prevention and reduction of blood loss | 
| 11/27/2014 | US20140349929 Multivalent fibronectin based scaffold domain proteins | 
| 11/27/2014 | US20140349925 Novel insulin derivatives | 
| 11/27/2014 | US20140349917 Targeted antimicrobial moieties | 
| 11/27/2014 | US20140349893 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes | 
| 11/27/2014 | US20140349855 T cell receptor display | 
| 11/27/2014 | US20140349371 Protein Refolding Method | 
| 11/27/2014 | US20140349344 Compositions and methods for purifying bax | 
| 11/27/2014 | US20140349315 Disulphide bond-stabilized functional soluble mhc class ii heterodimers | 
| 11/27/2014 | US20140348904 Exosomes With Transferrin Peptides | 
| 11/27/2014 | US20140348902 Tcl1 peptides for immunotherapy | 
| 11/27/2014 | US20140348870 Immunogenic plasmodium falciparum antigen compositions and uses thereof | 
| 11/27/2014 | US20140348869 Modified meningococcal fhbp polypeptides | 
| 11/27/2014 | US20140348868 Compositions comprising pneumococcal antigens | 
| 11/27/2014 | US20140348867 Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira | 
| 11/27/2014 | US20140348865 Immunogens based on an hiv-1 v1v2 site-of-vulnerability | 
| 11/27/2014 | US20140348864 Porcine circovirus type-2 (pcv2) subunit vaccine | 
| 11/27/2014 | US20140348863 Cmv antigens and uses thereof | 
| 11/27/2014 | US20140348862 Prame derived peptides and immunogenic compositions comprising these | 
| 11/27/2014 | US20140348861 Synthetic peptides and random copolymers for the treatment of autoimmune disorders | 
| 11/27/2014 | US20140348859 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules | 
| 11/27/2014 | US20140348854 HE4 Based Therapy For Malignant Disease | 
| 11/27/2014 | US20140348842 Tim-3 ligands and methods thereof | 
| 11/27/2014 | US20140348832 Inhibitors of t-cell activation | 
| 11/27/2014 | US20140348826 Engineering multifunctional and multivalent molecules with collagen xv trimerization domain | 
| 11/27/2014 | US20140348817 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | 
| 11/27/2014 | US20140348805 High affinity t cell receptor and use thereof | 
| 11/27/2014 | US20140348798 Seneca valley virus based compositions and methods for treating disease | 
| 11/27/2014 | US20140348794 Aav4 vector and uses thereof | 
| 11/27/2014 | US20140348790 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same | 
| 11/27/2014 | US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions | 
| 11/27/2014 | US20140348781 Conjugates of gm-csf and il-9, compositions and methods related thereto | 
| 11/25/2014 | US8898047 Methods for identifying inhibitors against viruses that use a class I fusion protein | 
| 11/25/2014 | US8895818 Transgenic plants with enhanced agronomic traits | 
| 11/25/2014 | US8895807 RabG3b gene and protein thereof for regulating late stage xylem development, method for promoting plant biomass and transgenic plant comprising the same | 
| 11/25/2014 | US8895715 S100B mini-promoters | 
| 11/25/2014 | US8895713 Clostridial neurotoxins with altered persistency | 
| 11/25/2014 | US8895711 Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP) | 
| 11/25/2014 | US8895705 Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof | 
| 11/25/2014 | US8895703 CA125 gene and its use for diagnostic and therapeutic interventions | 
| 11/25/2014 | US8895701 Peptide-conjugated oligonucleotide therapeutic and method of making and using same | 
| 11/25/2014 | US8895700 Monkey homolog of human interferon omega | 
| 11/25/2014 | US8895699 Stabilized compounds having secondary structure motifs | 
| 11/25/2014 | US8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use | 
| 11/25/2014 | US8895598 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection | 
| 11/25/2014 | US8895507 Modulation of synaptogenesis | 
| 11/25/2014 | US8895504 Amylin derivatives | 
| 11/25/2014 | US8895503 Pharmaceutical composition for transnasal administration of peptide hormones or cytokines | 
| 11/25/2014 | US8895502 β2-glycoprotein I peptide inhibitors | 
| 11/25/2014 | US8895500 Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same | 
| 11/25/2014 | US8895498 GIP and exendin hybrid polypeptides | 
| 11/25/2014 | US8895309 Myostatin inhibition for enhancing muscle and/or improving muscle function | 
| 11/25/2014 | US8895303 Method of cell culture and method of treatment comprising a vEPO protein variant | 
| 11/25/2014 | US8895286 Attenuated pestiviruses | 
| 11/25/2014 | US8895284 Class II human histone deacetylases, and uses related thereto | 
| 11/25/2014 | US8895283 Nucleic acid modifying enzymes | 
| 11/25/2014 | US8895282 Use of a substance for manufacturing of a medicament for treatment of common cold | 
| 11/25/2014 | US8895281 Method for preparing a site-specific physiologically active polypeptide conjugate | 
| 11/25/2014 | US8895277 Legume isoprene synthase for production of isoprene | 
| 11/25/2014 | US8895276 Microorganism variants having hydrocarbon producing ability and method for producing hydrocarbon using the same | 
| 11/25/2014 | US8895272 Methods for the economical production of biofuel from biomass | 
| 11/25/2014 | US8895263 Methods for suppressing toll-like receptor activity | 
| 11/25/2014 | US8895257 Proteins used for the diagnosis of lyme borreliosis |